Autobio Diagnostics Co Ltd
SSE:603658
Autobio Diagnostics Co Ltd
Net Income (Common)
Autobio Diagnostics Co Ltd
Net Income (Common) Peer Comparison
Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors
Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Autobio Diagnostics Co Ltd
SSE:603658
|
Net Income (Common)
¥1.3B
|
CAGR 3-Years
16%
|
CAGR 5-Years
17%
|
CAGR 10-Years
N/A
|
|
Shandong Weigao Group Medical Polymer Co Ltd
HKEX:1066
|
Net Income (Common)
¥2B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
6%
|
CAGR 10-Years
N/A
|
|
S
|
Shandong Pharmaceutical Glass Co Ltd
SSE:600529
|
Net Income (Common)
¥737.7m
|
CAGR 3-Years
12%
|
CAGR 5-Years
18%
|
CAGR 10-Years
19%
|
Winner Medical Co Ltd
SZSE:300888
|
Net Income (Common)
¥580.4m
|
CAGR 3-Years
-47%
|
CAGR 5-Years
6%
|
CAGR 10-Years
N/A
|
|
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
Net Income (Common)
¥1.7B
|
CAGR 3-Years
21%
|
CAGR 5-Years
19%
|
CAGR 10-Years
N/A
|
|
Autek China Inc
SZSE:300595
|
Net Income (Common)
¥686.3m
|
CAGR 3-Years
9%
|
CAGR 5-Years
24%
|
CAGR 10-Years
N/A
|
See Also
What is Autobio Diagnostics Co Ltd's Net Income (Common)?
Net Income (Common)
1.3B
CNY
Based on the financial report for Mar 31, 2024, Autobio Diagnostics Co Ltd's Net Income (Common) amounts to 1.3B CNY.
What is Autobio Diagnostics Co Ltd's Net Income (Common) growth rate?
Net Income (Common) CAGR 5Y
17%
Over the last year, the Net Income (Common) growth was 11%. The average annual Net Income (Common) growth rates for Autobio Diagnostics Co Ltd have been 16% over the past three years , 17% over the past five years .